|
Symbol Name ID |
Tafazzin
tafazzin, phospholipid-lysophospholipid transacylase MGI:109626 |
| * | Aspects of the system are reported to show a normal phenotype. |
| Darker colors indicate more annotations |
| Human Phenotypes | Endocardial fibroelastosis |
Dilated cardiomyopathy |
Hypertrophic cardiomyopathy |
Increased left ventricular end-diastolic volume |
Tricuspid regurgitation |
Arrhythmia |
Congestive heart failure |
| Disease(s) Associated with TAFAZZIN | |||||||
| Barth syndrome |
| Mouse Phenotypes | cardiovascular system phenotype |
abnormal myocardial fiber morphology |
abnormal heart morphology |
globular heart |
enlarged heart |
abnormal heart left ventricle morphology |
dilated heart left ventricle |
dilated cardiomyopathy |
decreased cardiac muscle contractility |
decreased heart left ventricle muscle contractility |
abnormal heart echocardiography feature |
|
| Availability | Mouse Genotype | |||||||||||
| Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/Gt(ROSA)26Sor+ | ||||||||||||
| Tafazzintm1Dost/Y | * | |||||||||||
| Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/? | ||||||||||||
| Tafazzinem1Xfa/Tafazzinem1Xfa Tg(myl7.L-cre)1118Tmhn/0 (conditional) |
||||||||||||
| Tafazzinem1Xfa/Y Tg(myl7.L-cre)1118Tmhn/0 (conditional) |
||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
|
|
|
||
Analysis Tools